Clinical trial
Comparison of Neuromuscular Blockade Monitoring Methods in Gynecologic Oncology Surgery: NMTCuff (Vision Duo) Versus Standard Train-of-Four (Acceleromyography)
NCT07925463 is registered in ClinicalTrials.gov with Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Neuromuscular Blockade Monitoring Methods in Gynecologic Oncology Surgery: NMTCuff (Vision Duo) Versus Standard Train-of-Four (Acceleromyography)
- Lead sponsor
- Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 1, 2026
- Completion date
- November 30, 2026
- Enrollment
- 45 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gynecologic cancer, neuromuscular blockade, residual neuromuscular block
Arms
As registered; 1 arm.
-
Simultaneous Dual NMT Cohort
A single cohort of patients where each patient receives two different neuromuscular transmission (NMT) monitoring methods simultaneously on opposite arms during elective laparoscopic gynecologic oncology surgery.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Time to Neuromuscular Recovery (TOF Ratio >= 0.90)
The time interval (measured in minutes) from the exact moment of the neuromuscular blockade reversal agent (Sugammadex 2 mg/kg) administration until the Train-of-Four (TOF) ratio reaches 90%. This recovery time will be tracked and recorded simultaneously for both the NMTCuff (Vision Duo) and the standard acceleromyography (AMG) devices using a digital stopwatch to evaluate the limits and correlation between the two monitoring methods.
Papers
PubMed papers this trial cites; 3 papers, results papers first, then newest first.
Lead sponsor's other trials
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, most recent start first.
+70 more trials
Similar trials
Same condition (Delayed Emergence from Anesthesia) and phase, most recent start first.
+33 more trials See the condition page